{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:04:03Z","timestamp":1788210243625,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":1626,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Associazione Sarda per la ricerca in Oncologia Ginecologica-ONLUS"},{"name":"Banco di Sardegna Foundation","award":["5335"],"award-info":[{"award-number":["5335"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jpainsymman.2015.04.014","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T16:37:08Z","timestamp":1432226228000},"page":"e1-e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Multitargeted Treatment Approach for Anemia and Cachexia in Metastatic Castration-Resistant Prostate Cancer"],"prefix":"10.1016","volume":"50","author":[{"given":"Antonio","family":"Macci\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gramignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia","family":"Madeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2015.04.014_bib1","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.1996.14.6.1753","article-title":"One hundred thirteen men with hormone-refractory prostate cancer died today","volume":"14","author":"Vogelzang","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1758834014529176","article-title":"Castration-resistant prostate cancer: latest evidence and therapeutic implications","volume":"6","author":"Suzman","year":"2014","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2006.09.039","article-title":"Interleukin 6 is associated with cachexia in patients with prostate cancer","volume":"69","author":"Kuroda","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib4","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1200\/JCO.2011.35.6295","article-title":"Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer","volume":"29","author":"Pili","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib5","first-page":"223","article-title":"Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer","volume":"7","author":"Gupta","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3324\/haematol.2014.112813","article-title":"The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study","volume":"100","author":"Macci\u00f2","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ygyno.2011.12.435","article-title":"A\u00a0randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecologic cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life","volume":"124","author":"Macci\u00f2","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nut.2005.06.003","article-title":"Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy","volume":"22","author":"Gramignano","year":"2006","journal-title":"Nutrition"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00109-009-0547-z","article-title":"Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia","volume":"88","author":"Mantovani","year":"2010","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib11","first-page":"231","article-title":"Proinflammatory cytokine interleukin-6 in prostate carcinogenesis","volume":"2","author":"Culig","year":"2014","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib12","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1634\/theoncologist.2010-0020","article-title":"Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study","volume":"15","author":"Macci\u00f2","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib13","first-page":"1","article-title":"Anemia in men with advanced prostate cancer: incidence, etiology, and treatment","volume":"6","author":"Nalesnik","year":"2004","journal-title":"Rev Urol"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0090-4295(99)80034-X","article-title":"Interleukin-6: a candidate mediator of human prostate cancer morbidity","volume":"45","author":"Willie","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib15","first-page":"674","article-title":"An essential role for nuclear factor kB in preventing TNF-\u03b1-induced cell death in prostate cancer cells","volume":"161","author":"Sumitomo","year":"1999","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib16","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1517\/13543784.2010.514262","article-title":"The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer","volume":"19","author":"Isaacs","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-013-2321-8","article-title":"Mechanisms of action of tasquinimod on the tumour microenvironment","volume":"73","author":"Raymond","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1464-410X.2011.10108.x","article-title":"Hepcidin, anaemia, and prostate cancer","volume":"107","author":"Tanno","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/pros.22815","article-title":"COX-2 inhibitors arrest prostate cancer cell cycle progression by down-regulation of kinetochore\/centromere proteins","volume":"74","author":"Bieniek","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.jpainsymman.2015.04.014_bib20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/13892037113149990066","article-title":"Studies on anticancer activities of lactoferrin and lactoferricin","volume":"14","author":"Yin","year":"2013","journal-title":"Curr Protein Pept Sci"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392415002365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392415002365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:15:38Z","timestamp":1760130938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392415002365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0885392415002365"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.04.014","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Multitargeted Treatment Approach for Anemia and Cachexia in Metastatic Castration-Resistant Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}